PersImmune Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
PersImmune is a clinical-stage biotechnology company focused on personalized cancer immunotherapy. Its approach centers on identifying the DNA alterations present in a patient’s tumor and generating highly specific T-cells from the patient’s own cells to target those neoantigens, aiming to deliver a treatment that is tailored to individual tumor signatures and potentially with fewer side effects than conventional therapies. The company emphasizes that its therapy is not edited or genetically engineered cells, and it is currently advancing a Phase 1 trial of its Personalized Adoptive Cellular Therapy for Neoantigens (PACTN) in patients with myelodysplastic syndrome, covering both early and late-stage cases. PersImmune operates from San Diego, California, and maintains a small team while pursuing development in the immunotherapy space.